These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38489753)

  • 1. The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
    Lim J; Rodriguez R; Williams K; Silva J; Gutierrez AG; Tyler P; Baharom F; Sun T; Lin E; Martin S; Kayser BD; Johnston RJ; Mellman I; Delamarre L; West NR; Müller S; Qu Y; Heger K
    Cancer Immunol Res; 2024 Jun; 12(6):663-672. PubMed ID: 38489753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN.
    Toufektchan E; Dananberg A; Striepen J; Hickling JH; Shim A; Chen Y; Nichols A; Duran Paez MA; Mohr L; Bakhoum SF; Maciejowski J
    Cancer Immunol Res; 2024 Jun; 12(6):673-686. PubMed ID: 38408184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.
    Tani T; Mathsyaraja H; Campisi M; Li ZH; Haratani K; Fahey CG; Ota K; Mahadevan NR; Shi Y; Saito S; Mizuno K; Thai TC; Sasaki N; Homme M; Yusuf CFB; Kashishian A; Panchal J; Wang M; Wolf BJ; Barbie TU; Paweletz CP; Gokhale PC; Liu D; Uppaluri R; Kitajima S; Cain J; Barbie DA
    Cancer Discov; 2024 May; 14(5):752-765. PubMed ID: 38227896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREX1 as a Novel Immunotherapeutic Target.
    Hemphill WO; Simpson SR; Liu M; Salsbury FR; Hollis T; Grayson JM; Perrino FW
    Front Immunol; 2021; 12():660184. PubMed ID: 33868310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin activates the cGAS-STING pathway by upregulating the TREX-1 (three prime repair exonuclease 1) expression in human melanoma.
    Ma Z; Xiong Q; Xia H; Liu W; Dai S; Cai S; Zhu Z; Yan X
    Bioengineered; 2021 Dec; 12(1):6448-6458. PubMed ID: 34519260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
    Vanpouille-Box C; Alard A; Aryankalayil MJ; Sarfraz Y; Diamond JM; Schneider RJ; Inghirami G; Coleman CN; Formenti SC; Demaria S
    Nat Commun; 2017 Jun; 8():15618. PubMed ID: 28598415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
    Shim A; Luan X; Zhou W; Crow YJ; Maciejowski J
    Hum Mol Genet; 2024 Sep; 33(18):1555-1566. PubMed ID: 38796715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.
    Ghosh M; Saha S; Li J; Montrose DC; Martinez LA
    Mol Cell; 2023 Jan; 83(2):266-280.e6. PubMed ID: 36638783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity.
    Maxwell MB; Hom-Tedla MS; Yi J; Li S; Rivera SA; Yu J; Burns MJ; McRae HM; Stevenson BT; Coakley KE; Ho J; Gastelum KB; Bell JC; Jones AC; Eskander RN; Dykhuizen EC; Shadel GS; Kaech SM; Hargreaves DC
    Cell; 2024 Jun; 187(13):3390-3408.e19. PubMed ID: 38754421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses.
    Flowers S; Petronella BA; McQueney MS; Fanelli B; Eisenberg W; Uveges A; Roden AL; Salowe S; Bommireddy V; Letourneau JJ; Huang CY; Beasley JR
    PLoS One; 2024; 19(8):e0305962. PubMed ID: 39178223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T Cells Produce IFN-α in the TREX1 D18N Model of Lupus-like Autoimmunity.
    Simpson SR; Rego SL; Harvey SE; Liu M; Hemphill WO; Venkatadri R; Sharma R; Grayson JM; Perrino FW
    J Immunol; 2020 Jan; 204(2):348-359. PubMed ID: 31826941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice.
    Li T; Yum S; Wu J; Li M; Deng Y; Sun L; Zuo X; Chen ZJ
    Proc Natl Acad Sci U S A; 2024 Sep; 121(38):e2411747121. PubMed ID: 39254994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.
    Gao D; Li T; Li XD; Chen X; Li QZ; Wight-Carter M; Chen ZJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5699-705. PubMed ID: 26371324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing.
    Zhou W; Mohr L; Maciejowski J; Kranzusch PJ
    Mol Cell; 2021 Feb; 81(4):739-755.e7. PubMed ID: 33606975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Activation of Innate Immunity Depends Strongly on the Intracellular Level of TREX1 and Sensing of Incomplete Reverse Transcription Products.
    Kumar S; Morrison JH; Dingli D; Poeschla E
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29769349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer.
    Sun Y; Patterson-Fortin J; Han S; Li Z; Nowicka Z; Hirohashi Y; Kilgas S; Yi JK; Spektor A; Fendler W; Konstantinopoulos PA; Chowdhury D
    Nat Commun; 2024 Aug; 15(1):6676. PubMed ID: 39107288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
    Diamond JM; Vanpouille-Box C; Spada S; Rudqvist NP; Chapman JR; Ueberheide BM; Pilones KA; Sarfraz Y; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Aug; 6(8):910-920. PubMed ID: 29907693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.
    Gray EE; Treuting PM; Woodward JJ; Stetson DB
    J Immunol; 2015 Sep; 195(5):1939-43. PubMed ID: 26223655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER-directed TREX1 limits cGAS activation at micronuclei.
    Mohr L; Toufektchan E; von Morgen P; Chu K; Kapoor A; Maciejowski J
    Mol Cell; 2021 Feb; 81(4):724-738.e9. PubMed ID: 33476576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.